|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets: | ||||||||||
| Cash and cash equivalents | ||||||||||
| Restricted cash, short-term | ||||||||||
| Short-term investments | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Total current assets | ||||||||||
| Deferred offering costs | ||||||||||
| Marketable securities held in Trust Account | ||||||||||
| Restricted cash, long-term | ||||||||||
| Property, equipment and software, net | ||||||||||
| Operating lease right-of-use assets | ||||||||||
| Other assets | ||||||||||
| Total assets | ||||||||||
| Liabilities and stockholders’ equity | ||||||||||
| Current liabilities: | ||||||||||
| Accrued expenses | ||||||||||
| Accrued offering costs | ||||||||||
| Promissory note — related party | ||||||||||
| Promissory note – related party | ||||||||||
| Accounts payable | ||||||||||
| Accrued expenses and other current liabilities | ||||||||||
| Current portion of operating lease liabilities | ||||||||||
| Short-term notes payable | ||||||||||
| Total current liabilities | ||||||||||
| FPA liability | ||||||||||
| Deferred underwriting fee payable | ||||||||||
| Long-term notes payable | ||||||||||
| Warrant liabilities | ||||||||||
| Warrant liability | ||||||||||
| Non-current portion of operating lease liabilities | ||||||||||
| Other long-term liability | ||||||||||
| Long-term deferred rent | ||||||||||
| Total liabilities | ||||||||||
| Common stock subject to possible redemption 41,400,000 and 0 shares at redemption value at September 30, 2021 and December 31, 2020, respectively | ||||||||||
| Stockholders’ equity: | ||||||||||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized, none issued and none outstanding as of March 31, 2023 and December 31, 2022 | ||||||||||
| Common stock, value | ||||||||||
| Class A Common Stock | ||||||||||
| Class B Common Stock | ||||||||||
| Total common stock, value | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated other comprehensive income | ||||||||||
| Accumulated deficit | ||||||||||
| Total stockholders’ equity | ||||||||||
| Total liabilities and stockholders’ equity |
Loading...